Determining the Mechanism of Banxia Xiexin Decoction for Gastric Cancer Treatment through Network Analysis and Experimental Validation

被引:1
作者
Li, Yaxing [1 ]
Li, Ling [1 ]
Wang, Xue [1 ]
Huang, Hailiang [2 ]
Han, Tao [1 ]
机构
[1] Shandong Univ Tradit Chinese Med, Coll Tradit Chinese Med, Pharmacol Tradit Chinese Med Formulas, Jinan 250000, Shandong, Peoples R China
[2] Shandong Univ Tradit Chinese Med, Sch Rehabil Med, Rehabil Med & Physiotherapy, Jinan 250355, Shandong, Peoples R China
来源
ACS OMEGA | 2024年 / 9卷 / 09期
关键词
AUTOPHAGY; TUMORIGENESIS; INHIBITION;
D O I
10.1021/acsomega.3c06330
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Gastric cancer (GC) is a widespread malignancy. Banxia Xiexin decoction (BXD) has been used for GC treatment, but the specific mechanisms underlying its therapeutic effects remain controversial. This study used a comprehensive approach to network pharmacology combined with experimental validation to elucidate the mechanism of BXD's anti-GC effects. Initially, we used the UHPLC-LTQ-Orbitrap-MS/MS technology to identify the main chemical constituents of BXD, as well as potential targets associated with these constituents. Then, we employed the Genecard and Online Mendelian Inheritance in Man (OMIM) to determine the targets specifically related to GC. We employed a combination of Gene Ontology (GO), the Kyoto Encyclopedia of Genes and Genomes pathway, and protein-protein interaction analysis to predict the crucial targets of BXD and uncover the pathways involved in its therapeutic effects against GC. The results were subsequently verified through cell experiments. The analysis revealed 174 common targets shared by BXD and GC. GO enrichment analysis highlighted biological processes, such as autophagy, protein kinase activity, and apoptosis. Moreover, the enrichment analysis revealed several significant pathways that serve as the primary mechanisms by which BXD exerts its effects. Notably, these pathways include PI3K-Akt, HIF-1, and Pathways in cancer. Subsequent in vitro experiments demonstrated that BXD effectively hindered GC cell proliferation, stimulated autophagy, and facilitated apoptosis by PI3K-Akt-mTOR signaling pathway regulation. These findings reveal the effectiveness of BXD against GC through diverse components, targets, and pathways, indicating that BXD holds potential therapeutic value in GC treatment. This study uncovers the intricate biological mechanisms that underlie BXD's efficacy in treating GC through the integration of network pharmacology analysis and rigorous in vitro experiments.
引用
收藏
页码:10119 / 10131
页数:13
相关论文
共 37 条
  • [1] OMIM.org: leveraging knowledge across phenotype-gene relationships
    Amberger, Joanna S.
    Bocchini, Carol A.
    Scott, Alan F.
    Hamosh, Ada
    [J]. NUCLEIC ACIDS RESEARCH, 2019, 47 (D1) : D1038 - D1043
  • [2] Changing profiles of cancer burden worldwide and in China: a secondary analysis of the global cancer statistics 2020
    Cao, Wei
    Chen, Hong-Da
    Yu, Yi-Wen
    Li, Ni
    Chen, Wan-Qing
    [J]. CHINESE MEDICAL JOURNAL, 2021, 134 (07) : 783 - 791
  • [3] Efficacy of Banxia Xiexin decoction for chronic atrophic gastritis: A systematic review and meta-analysis
    Cao, Yang
    Zheng, Yixin
    Niu, Jingbin
    Zhu, Chunmei
    Yang, Decai
    Rong, Fen
    Liu, Guoping
    [J]. PLOS ONE, 2020, 15 (10):
  • [4] Integrating network analysis and experimental validation to reveal the mitophagy-associated mechanism of Yiqi Huoxue (YQHX) prescription in the treatment of myocardial ischemia/reperfusion injury
    Chen, Mingtai
    Zhong, Guofu
    Liu, Mengnan
    Zhou, Jie
    Chen, Jianping
    Zhang, Mingsheng
    Liu, Qiang
    Tong, Guangdong
    Luan, Jienan
    Zhou, Hua
    He, Hao
    [J]. PHARMACOLOGICAL RESEARCH, 2023, 189
  • [5] Autophagy-Associated Immunogenic Modulation and Its Applications in Cancer Therapy
    Duan, Zhuxi
    Shi, Yu
    Lin, Qun
    Hamai, Ahmed
    Mehrpour, Maryam
    Gong, Chang
    [J]. CELLS, 2022, 11 (15)
  • [6] Banxia xiexin decoction affects drug sensitivity in gastric cancer cells by regulating MGMT expression via IL-6/JAK/STAT3-mediated PD-L1 activity
    Feng, Xuan
    Xue, Feng
    He, Guihua
    Ni, Qing
    Huang, Suiping
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2021, 48 (02)
  • [7] Banxia Xiexin Decoction Inhibits the Expression of PD-L1 Through Multi-Target and Multi-Pathway Regulation of Major Oncogenes in Gastric Cancer
    Feng, Xuan
    Xue, Feng
    He, Guihua
    Huang, Suiping
    Ni, Qing
    [J]. ONCOTARGETS AND THERAPY, 2021, 14 : 3297 - 3307
  • [8] PI3K-AKT-mTOR and NFκB Pathways in Ovarian Cancer: Implications for Targeted Therapeutics
    Ghoneum, Alia
    Said, Neveen
    [J]. CANCERS, 2019, 11 (07)
  • [9] Myricetin induces apoptosis and autophagy in human gastric cancer cells through inhibition of the PI3K/Akt/mTOR pathway
    Han, So-Hee
    Lee, Jae-Han
    Woo, Joong-Seok
    Jung, Gi-Hwan
    Jung, Soo-Hyun
    Han, Eun-Ji
    Kim, Bumseok
    Cho, Sung Dae
    Nam, Jeong Seok
    Che, Jeong Hwan
    Jung, Ji-Youn
    [J]. HELIYON, 2022, 8 (05)
  • [10] The Importance of mTORC1-Autophagy Axis for Skeletal Muscle Diseases
    Han, Xujun
    Goh, Kah Yong
    Lee, Wen Xing
    Choy, Sze Mun
    Tang, Hong-Wen
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (01)